×
About 94,845 results

ALLMedicine™ Myocardial Infarction Center

Research & Reviews  31,011 results

Re-examining the Association Between E-Cigarette Use and Myocardial Infarction: A Cauti...
https://doi.org/10.1016/j.amepre.2021.05.003
American Journal of Preventive Medicine; Critcher CR, Siegel M

Jul 26th, 2021 - Cross-sectional analyses have suggested that e-cigarette use, independent of combustible cigarette use, elevates the risk of myocardial infarction. Previous researchers confused their own models' assumptions that these risks were independent with ...

Direct cardiac reprogramming comes of age: Recent advance and remaining challenges.
https://doi.org/10.1016/j.semcdb.2021.07.010
Seminars in Cell & Developmental Biology; Xie Y, Liu J et. al.

Jul 26th, 2021 - The adult human heart has limited regenerative capacity. As such, the massive cardiomyocyte loss due to myocardial infarction leads to scar formation and adverse cardiac remodeling, which ultimately results in chronic heart failure. Direct cardiac...

The Recanalization After Thrombolysis as Surrogate for Clinical Outcomes in Patients wi...
https://doi.org/10.1111/bcp.15004
British Journal of Clinical Pharmacology; Zhu Y, Chen S et. al.

Jul 26th, 2021 - Thrombolytic therapy has been known to be effective in reducing clinical outcomes and increasing recanalization rate among patients with ST-segment elevation acute myocardial infarction (STEMI). However, whether post-thrombolysis recanalization co...

Editorial for "Inflammation in Remote Myocardium and Left Ventricular Remodeling After ...
https://doi.org/10.1002/jmri.27861
Journal of Magnetic Resonance Imaging : JMRI; Masci PG, Bogaert J

Jul 26th, 2021 - Editorial for "Inflammation in Remote Myocardium and Left Ventricular Remodeling After Acute Myocardial Infarction: A Pilot Study Using T2 Mapping".|2021|Masci PG,Bogaert J,|

Renal Dysfunction as a Predictor of Slow-Flow/No-Reflow Phenomenon and Impaired ST Segm...
https://doi.org/10.1253/circj.CJ-21-0221
Circulation Journal : Official Journal of the Japanese Ci... Kai T, Oka S et. al.

Jul 26th, 2021 - The slow-flow/no-reflow phenomenon and impaired ST segment resolution (STR) following primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) predict unfavorable prognosis and are characterized by obstruction...

see more →

Guidelines  34 results

Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation R...
https://doi.org/10.1001/jama.2021.4987
JAMA , Krist AH et. al.

Apr 27th, 2021 - Hypertension is a prevalent condition that affects approximately 45% of the adult US population and is the most commonly diagnosed condition at outpatient office visits. Hypertension is a major contributing risk factor for heart failure, myocardia...

Myocardial Infarction Without Obstructive Coronary Artery Disease (MINOCA): A Practical...
https://doi.org/10.1016/j.cpcardiol.2020.100761
Current Problems in Cardiology; Ciliberti G, Compagnucci P et. al.

Dec 28th, 2020 - Myocardial infarction without obstructive coronary artery disease (MINOCA) is defined by the evidence of spontaneous acute myocardial infarction (MI) and angiographic exclusion of coronary stenoses ≥50% in any potential infarct related artery, aft...

2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement o...
https://doi.org/10.1016/j.cjca.2020.04.004
The Canadian Journal of Cardiology; Deyell MW, AbdelWahab A et. al.

Jun 16th, 2020 - This Canadian Cardiovascular Society position statement is focused on the management of sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) that occurs in patients with structural heart disease (SHD), including previous myocar...

Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Stat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173829
Journal of the American College of Cardiology; Mahmud E, Dauerman HL et. al.

Apr 24th, 2020 - The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, ...

Clinical Summary: Screening for Cardiovascular Disease Risk With Electrocardiography
https://allmedx.com/USPSTFPDF/cvd-screening-with-ecg-clinical-summary.pdf

Jun 5th, 2018 - Clinical Summary: Screening for Cardiovascular Disease Risk With Electrocardiography Population Adults at low risk of CVD events Adults at intermediate or high risk of CVD events Recommendation Do not screen with resting or exercis...

see more →

Drugs  1,920 results see all →

Clinicaltrials.gov  1,345 results

XIENCE 28 Global Study
https://clinicaltrials.gov/ct2/show/NCT03355742

May 5th, 2020 - The XIENCE 28 Global Study will evaluate the safety of 1-month DAPT following XIENCE implantation in HBR patients. A minimum of 800 to a maximum of 960 subjects will be registered from approximately 50 sites globally and subject registration is ca...

INcreasing Statin Prescribing in HIV Behavioral Economics REsearch
https://clinicaltrials.gov/ct2/show/NCT03687060

May 4th, 2020 - Cardiovascular disease is a major cause of morbidity and mortality among people living with HIV. Recent studies have demonstrated that patients with HIV experience a 50-100% increased risk of myocardial infarction and stroke compared to HIV-uninfe...

Brilinta Clinical Experience Investigation
https://clinicaltrials.gov/ct2/show/NCT03212287

Apr 30th, 2020 - To confirm the following safety topics in patients to be treated with BRILINTA tablets 60 mg or 90 mg (hereinafter referred to as "BRILINTA") in clinical practice in the post-marketing phase. Profile and incidence of ADRs The CEI will be conducted...

Study of Heart Transplant Rejection
https://clinicaltrials.gov/ct2/show/NCT00042614

Apr 29th, 2020 - Cardiac transplantation has been successful in improving survival in end stage heart failure. But graft rejection has limited survival after transplantation. In the first year, acute cellular rejection and infection remain the most common causes o...

Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor
https://clinicaltrials.gov/ct2/show/NCT02545933

Apr 29th, 2020 - Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor represents the standard of care for the long-term secondary prevention of atherothrombotic events in patients with myocardial infarction (MI). The novel P2Y12 receptor in...

see more →

News  3,625 results

 An Intentional Expert Witness
https://www.medscape.com/viewarticle/955075

Jul 20th, 2021 - After my early outing as an expert witness, defending the care of a residency classmate against the testimony of one of our former faculty, I decided that I probably needed to learn more about what appeared to be a viable sideline for someone who ...

South Asian Ancestry Linked to Increased Risk for Heart Disease
https://www.medscape.com/viewarticle/954651

Jul 11th, 2021 - Individuals of South Asian ancestry face twice the risk of heart disease, compared with individuals of European descent, yet existing risk calculators fail to account for this disparity, according to the results of a new study. These findings conf...

More Evidence Epilepsy Tied to Risk for Major Cardiovascular Events
https://www.medscape.com/viewarticle/954347

Jul 6th, 2021 - More data link epilepsy to a significantly increased risk for major cardiovascular events, including stroke or arrhythmia. In a large retrospective cohort study, risk for cardiovascular events was 58% greater among patients with epilepsy who under...

PCI for Chronic Total Occlusion More Successful After Coronary CTA
https://www.medscape.com/viewarticle/954228

Jul 5th, 2021 - NEW YORK (Reuters Health) - The success rate of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) is improved by performing coronary computed tomography angiography (CCTA) beforehand, with numerically fewer instances of co...

Self-Injected Antiplatelet for Acute MI Enters Phase 3 Testing
https://www.medscape.com/viewarticle/954030

Jun 29th, 2021 - A phase 3 study testing the safety and efficacy of the fast-acting, self-administered P2Y12 receptor antagonist selatogrel (Idorsia Pharmaceuticals) for the treatment of suspected acute myocardial infarction (AMI) is underway, the company has anno...

see more →

Patient Education  3 results see all →